- OUTREACH, RECRUITMENT, AND EDUCATION CORE Since its inception, the Mayo Outreach, Recruitment, and Education Core (OREC;formerly the Education & Information Transfer Core) has actively served our patients, their caregivers, local communities, and care providers through both independent and collaborative efforts. Going forward under the new application, our activities align closely with the goals of the National Plan to Address Alzheimer's Disease to increase awareness of ADRC activity, educate the public about AD and non-AD dementia, partner with care providers across all levels to enhance dementia care quality and efficiency, and provide education and support programs to patients with dementia and their families. To achieve these goals, our core will leverage electronic and social media and deliver new and innovative support programs for patients and caregivers. We will continue to assist the Clinical Core in recruitment and retention of participants for center and center-related studies, including clinical trials and national biomarker and genetics initiatives. We will extend our outreach and educational activities to support the center-affiliated Mayo Clinic Study of Aging, which shares data on cognitively normal older adults with ADRC investigators. Importantly, the Mayo OREC will provide education, support services, and programs to traditionally underserved populations (i.e., rural residents in Rochester;African American elders in Jacksonville), thereby facilitating representation of these demographics in ADRC research. ADRC investigators and personnel will continue to support OREC goals by participating in educational programs and activities in international, national, regional, local, and institutional venues. These activities include traditional research presentations at scientific meetings, training and education of professionals and paraprofessionals, and support and education services for patients and caregivers. We will continue to contribute to the leadership of, and work synergistically with, the Alzheimer's Association, organizations representing the interests of patients with non-AD dementia, and other local, state, and national entities invested in dementia education and patient care needs. We will continue to promote and cultivate programs to educate and train the next generation of dementia investigators and clinicians by providing access to high quality, evidence-based training activities and continuing to partner with Mayo's Clinical and Translational Science Award (CTSA) program. We will also continue our tradition of strongly supporting junior and minority investigators. In summary, the OREC going forward will maintain its past strengths, address all requirements of the current RFP, and continue to support the Center in achieving its recruitment goals.
- OUTREACH, RECRUITMENT, AND EDUCATION CORE The Mayo OREC provides the highest quality, innovative outreach, education, and supportive activities to families, caregivers, healthcare providers, and patients with MCI, AD, and related dementias. Core activities align closely with the goals of the National Plan to Address Alzheimer's Disease to increase awareness of ADRC activity, educate the public about AD and non-AD dementia, partner with care providers across all levels to enhance dementia care quality and efficiency, and provide education and support programs to patients with dementia and their families. These activities support recruitment and retention goals of the Mayo ADRC clinical core and provide unique opportunities to train the next generation of dementia-focused clinicians and junior investigators through participation in innovative, evidence-based service delivery programs and cooperation with the Mayo Clinical and Translational Science Award Program.
|Tosto, Giuseppe; Bird, Thomas D; Bennett, David A et al. (2016) The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol 73:1231-1237|
|Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717|
|Ma, Li; Allen, Mariet; Sakae, Nobutaka et al. (2016) Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains. Mol Neurodegener 11:72|
|Kantarci, Kejal; Lowe, Val J; Lesnick, Timothy G et al. (2016) Early Postmenopausal Transdermal 17Î²-Estradiol Therapy and Amyloid-Î² Deposition. J Alzheimers Dis 53:547-56|
|Zheng, Honghua; Liu, Chia-Chen; Atagi, Yuka et al. (2016) Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging 42:132-41|
|Staubo, Sara C; Aakre, Jeremiah A; Vemuri, Prashanthi et al. (2016) Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement :|
|LabbÃ©, Catherine; Heckman, Michael G; Lorenzo-Betancor, Oswaldo et al. (2016) MAPT haplotype diversity in multiple system atrophy. Parkinsonism Relat Disord 30:40-5|
|McCutcheon, Sarah T; Han, Dingfen; Troncoso, Juan et al. (2016) Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. Int J Geriatr Psychiatry 31:1301-1311|
|Forrester, Sarah N; Gallo, Joseph J; Smith, Gwenn S et al. (2016) Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. Am J Geriatr Psychiatry 24:117-25|
|Day, Gregory S; Musiek, Erik S; Roe, Catherine M et al. (2016) Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study. JAMA Neurol 73:1125-32|
Showing the most recent 10 out of 813 publications